Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Final enrollment: 806 participants (planned 4)
    • Eligibility criteria expanded, about 7 words
    • Site details revised
  2. Start date: Feb 18, 2026 to Apr 18, 2026v4
  3. Start date: Jan 2, 2026 to Feb 18, 2026
    • Primary completion date: Aug 1, 2026 to Jun 1, 2026
    • Study completion date: Sep 1, 2026 to Jul 1, 2026
    v3
  4. Start date: Dec 1, 2025 to Jan 2, 2026v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this retrospective cohort study is to compare the safety and efficacy of induction agents for tracheal intubation in critically ill adult patients.
Trial Details
NCT Number NCT07222007
Lead Sponsor Zeliha Alicikus
Collaborators: University of Florida
Conditions
(from sponsor)		 Critically Ill, Intubation Complication, Oxygenation, Airway Management, Propofol, Ketamine
Related terms Critical Illness
Enrollment 806 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov